Nature Communications
This page lists scientific publications related to the EVAg project that were published in the journal entitled " Nature Communications ". The default filter is set to "publications for which the research was funded by the EVAg project". You can change this filter to another value by picking a different filter from the drop-down list and clicking on the "Apply" button.7 publications displayed
Date |
Name | Authors | EVAg |
|---|---|---|---|
| Feb 2022 | Multilateral benefit-sharing from digital sequence information will support both science and biodiversity conservation | Scholz Amber Hartman, Freitag Jens, Lyal Christopher H. C., Sara Rodrigo, Cepeda Martha Lucia, Cancio Ibon, Sett Scarlett, Hufton Andrew Lee, Abebaw Yemisrach, Bansal Kailash, Benbouza Halima, Boga Hamadi Iddi, Brisse Sylvain, Bruford Michael W., Clissold Hayley, Cochrane Guy, Coddington Jonathan A., Deletoille Anne-Caroline, García-Cardona Felipe, Hamer Michelle, Hurtado-Ortiz Raquel, Miano Douglas W., Nicholson David, Oliveira Guilherme, Bravo Carlos Ospina, Rohden Fabian, Seberg Ole, Segelbacher Gernot, Shouche Yogesh, Sierra Alejandra, Karsch-Mizrachi Ilene, da Silva Jessica, Hautea Desiree M., da Silva Manuela, Suzuki Mutsuaki, Tesfaye Kassahun, Tiambo Christian Keambou, Tolley Krystal A., Varshney Rajeev, Zambrano María Mercedes, Overmann Jörg | Research funded by EVAg, Published by EVAg partner |
| Dec 2021 | Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model | Driouich Jean-Sélim, Cochin Maxime, Lingas Guillaume, Moureau Grégory, Touret Franck, Petit Paul-Rémi, Piorkowski Géraldine, Barthélémy Karine, Laprie Caroline, Coutard Bruno, Guedj Jérémie, de Lamballerie Xavier, Solas Caroline, Nougairède Antoine | Research funded by EVAg, Published by EVAg partner |
| Dec 2021 | Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection | Wettstein Lukas, Weil Tatjana, Conzelmann Carina, Müller Janis A., Groß Rüdiger, Hirschenberger Maximilian, Seidel Alina, Klute Susanne, Zech Fabian, Prelli Bozzo Caterina, Preising Nico, Fois Giorgio, Lochbaum Robin, Knaff Philip Maximilian, Mailänder Volker, Ständker Ludger, Thal Dietmar Rudolf, Schumann Christian, Stenger Steffen, Kleger Alexander, Lochnit Günter, Mayer Benjamin, Ruiz-Blanco Yasser B., Hoffmann Markus, Sparrer Konstantin M. J., Pöhlmann Stefan, Sanchez-Garcia Elsa, Kirchhoff Frank, Frick Manfred, Münch Jan | Research funded by EVAg, Published by EVAg end-user |
| Dec 2020 | Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis | Shannon Ashleigh, Selisko Barbara, Le Nhung-Thi-Tuyet, Huchting Johanna, Touret Franck, Piorkowski Géraldine, Fattorini Véronique, Ferron François, Decroly Etienne, Meier Chris, Coutard Bruno, Peersen Olve, Canard Bruno | Research funded by EVAg, Published by EVAg partner |
| Dec 2020 | Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients | Funnell S. G. P., Dowling W. E., Muñoz-Fontela C., Gsell P.-S., Ingber D. E., Hamilton G. A., Delang L., Rocha-Pereira J., Kaptein S., Dallmeier K. H., Neyts J., Rosenke K., de Wit E., Feldmann H., Maisonnasse P., Le Grand R., Frieman M. B., Coleman C. M. | Research funded by EVAg, Published by EVAg partner |
| Dec 2020 | A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics | Lyngbakken Magnus Nakrem, Berdal Jan-Erik, Eskesen Arne, Kvale Dag, Olsen Inge Christoffer, Rueegg Corina Silvia, Rangberg Anbjørg, Jonassen Christine Monceyron, Omland Torbjørn, Røsjø Helge, Dalgard Olav | Research funded by EVAg, Published by EVAg end-user |
| Feb 2016 | Vector-free transmission and persistence of Japanese encephalitis virus in pigs | Ricklin Meret E., García-Nicolás Obdulio, Brechbühl Daniel, Python Sylvie, Zumkehr Beatrice, Nougairede Antoine, Charrel Remi N., Posthaus Horst, Oevermann Anna, Summerfield Artur | Research funded by EVAg, Published by EVAg partner |